AKRO
Price
$41.13
Change
+$1.52 (+3.84%)
Updated
Apr 24, 04:49 PM (EDT)
Capitalization
3.07B
26 days until earnings call
TRDA
Price
$8.78
Change
+$0.07 (+0.80%)
Updated
Apr 24, 02:52 PM (EDT)
Capitalization
327.45M
14 days until earnings call
Ad is loading...

AKRO vs TRDA

Header iconAKRO vs TRDA Comparison
Open Charts AKRO vs TRDABanner chart's image
Akero Therapeutics
Price$41.13
Change+$1.52 (+3.84%)
Volume$1.5K
Capitalization3.07B
Entrada Therapeutics
Price$8.78
Change+$0.07 (+0.80%)
Volume$953
Capitalization327.45M
AKRO vs TRDA Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. TRDA commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Buy and TRDA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (AKRO: $39.61 vs. TRDA: $8.71)
Brand notoriety: AKRO and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 112% vs. TRDA: 108%
Market capitalization -- AKRO: $3.07B vs. TRDA: $327.45M
AKRO [@Biotechnology] is valued at $3.07B. TRDA’s [@Biotechnology] market capitalization is $327.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 1 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 1 green, 4 red.
According to our system of comparison, AKRO is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • AKRO’s TA Score: 5 bullish, 5 bearish.
  • TRDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AKRO and TRDA are a good buy in the short-term.

Price Growth

AKRO (@Biotechnology) experienced а +5.80% price change this week, while TRDA (@Biotechnology) price change was +10.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.74%. For the same industry, the average monthly price growth was -5.54%, and the average quarterly price growth was -12.32%.

Reported Earning Dates

AKRO is expected to report earnings on Aug 08, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($3.07B) has a higher market cap than TRDA($327M). AKRO YTD gains are higher at: 42.380 vs. TRDA (-49.624). TRDA has higher annual earnings (EBITDA): 50.8M vs. AKRO (-247.37M). AKRO has more cash in the bank: 743M vs. TRDA (420M). AKRO has less debt than TRDA: AKRO (36.5M) vs TRDA (59.2M). TRDA has higher revenues than AKRO: TRDA (211M) vs AKRO (0).
AKROTRDAAKRO / TRDA
Capitalization3.07B327M937%
EBITDA-247.37M50.8M-487%
Gain YTD42.380-49.624-85%
P/E RatioN/A5.18-
Revenue0211M-
Total Cash743M420M177%
Total Debt36.5M59.2M62%
FUNDAMENTALS RATINGS
AKRO: Fundamental Ratings
AKRO
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
57
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKROTRDA
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 17 days ago
84%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRLCX21.13N/A
N/A
Nuveen Large Cap Value Retire
BTBFX58.06N/A
N/A
Boston Trust Asset Management
FTPIX67.31N/A
N/A
Invesco Technology R5
CNGLX18.56N/A
N/A
Commonwealth Global
HSMRX11.23N/A
N/A
Hartford Small Cap Value R3

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
N/A
CRNX - TRDA
52%
Loosely correlated
+3.55%
ATXS - TRDA
52%
Loosely correlated
+12.55%
RXRX - TRDA
50%
Loosely correlated
-0.89%
ARCT - TRDA
49%
Loosely correlated
+3.78%
TECH - TRDA
48%
Loosely correlated
+2.20%
More